• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

5

CATEGORIES

  • 2
  • 2
  • 2
  • 1
  • 1
  • 1

PRICE

0
3
4
6

PUBLISHED

0
0
0
6

PRODUCT TYPE

3
3

Search "Diabetes R & D Pipeline: DGAT1 Inhibitors" returned 6 results.

PRODUCT TITLE
Competitor Analysis - Targeted Therapy of Obesity Competitor Analysis - Targeted Therapy of Obesity - Product Thumbnail Image

Competitor Analysis - Targeted Therapy of Obesity

The present Competitive Intelligence Report about Targeted Therapy of Obesity provides a competitor evaluation in the field of novel molecules being developed for treatment of obesity as of March 2011...

March 2011
FROM
VIA Pharmaceuticals, Inc. - Product Pipeline Review - 2012 VIA Pharmaceuticals, Inc. - Product Pipeline Review - 2012 - Product Thumbnail Image

VIA Pharmaceuticals, Inc. - Product Pipeline Review - 2012

VIA Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “VIA Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the...

November 2012
FROM
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitors bring added benefits to diabetes therapy. Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitors bring added benefits to diabetes therapy. - Product Thumbnail Image

Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitors bring added benefits to diabetes therapy.

Introduction Datamonitor forecasts the non-insulins antidiabetics market to grow to $18.8 billion in 2019 for the seven major markets, with pipeline products contributing 39% of sales. GLP-1 agonists...

December 2010
FROM
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers - Product Thumbnail Image

Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers

Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitors bring added benefits to diabetes therapy The non-insulins antidiabetics market is forecast to grow to $18 8 billion...

December 2010
FROM
VIA Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010 VIA Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010 - Product Thumbnail Image

VIA Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010

VIA Pharmaceuticals, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “VIA Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010” provides data on...

November 2010
FROM

VIA Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010

VIA Pharmaceuticals, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “VIA Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010” provides data on...

November 2010
FROM
Loading Indicator